Buzz Stocks: Ariad Pharmaceuticals, Inc., Tiffany & Co., and TiVo Corp

Today's stocks to watch in the news include Ariad Pharmaceuticals, Inc. (ARIA), Tiffany & Co. (TIF), and TiVo Corp (TIVO)

Nov 29, 2016 at 9:10 AM
facebook twitter linkedin


U.S. stock futures are signaling a solid start, following an upbeat gross domestic product (GDP) reading. Among specific equities in focus today are drugmaker Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), jewelry retailer Tiffany & Co. (NYSE:TIF), and video tech stock TiVo Corp (NASDAQ:TIVO). Here's a quick look at what's driving ARIA, TIF, and TIVO.

  • ARIA shares have caught fire in pre-market trading, after the Food and Drug Administration (FDA) announced full approval and a label update for the company's leukemia treatment Iclusig. Specifically, the pharmaceutical stock is 3.3% higher after settling yesterday at $13.69 -- on a 57% month-to-date gain -- and could make a run at a fresh three-year high today. With Ariad Pharmaceuticals, Inc. breaking out of late, short sellers may find themselves increasingly under water. Nearly 23% of the stock's float is sold short, which translates into roughly four days' worth of pent-up buying power, at ARIA's average rate of trading.
  • TIF is pointed 5.8% higher ahead of the open, after the company topped the Street's consensus earnings estimate and posted its first sales increase in eight quarters. After ending yesterday at $78.14, the stock is set to touch an annual high out of the gate, assuming its pre-market gains materialize. This should come as a boon to short-term options traders, who have been quite call-tilted. Tiffany & Co. sports a Schaeffer's put/call open interest ratio (SOIR) of 0.88, which ranks in the low 12th percentile of its 12-month range.
  • TIVO's licensing agreement with Netflix, Inc. (NASDAQ:NFLX) has shares of the former nearly 6.8% higher in electronic trading. Already, it's been a great year for TiVo Corp stock, which has tacked on nearly 25% to trade at $20.75. Not surprisingly, option buyers have been targeting calls over puts. TIVO sports a 50-day International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX) call/put volume ratio of 6.11, outstripping 69% of all readings from the prior year.

Stay on top of overnight news & big morning movers. Sign up now for Schaeffer's Opening View.

 

Stop leaving money on the table with the same old broken options trading approach...

There is no options strategy that more perfectly capitalizes during earnings season better than this simple call and put buying strategy. Perfect for aggressive traders looking to recover their suffering portfolios so far in 2022. With the simplest possible options strategy, Schaeffer's team with 100+ years of options trading excellence, target 200% gains on every single trade. So many trades are being beaten down by the market, but don't be one of them! Don't waste another second... join us right now before the next trade is released! 

 
Best stocks for October and worst stocks for October
 


 


 
Special Offers from Schaeffer's Trading Partners